 Phase II trials involve patients with the condition the drug is intended to treat to test for safety and minimal efficacy in a somewhat larger group of people.Phase III trials involve one to five thousand patients to determine whether the drug is effective in treating the condition it is intended to be used for.After this stage, a new drug application is submitted.